spin-off News
Most Popular spin-off Story
GSK spins off Tempero in Mass.
Xconomy reports that GlaxoSmithKline has spun-off Tempero Pharmaceuticals from GSK's Immuno-Inflammation Centre of Excellence in Drug Discovery. The new company, which will be based in biotech hotbed Read more...
Latest Headlines
- October 25, 2011
- September 9, 2011
- November 11, 2010
- August 13, 2010
- October 7, 2009
- July 13, 2009
- May 15, 2009
- April 16, 2009
- April 16, 2009
- January 22, 2009
- December 22, 2008
- December 2, 2008
- October 21, 2008
- October 13, 2008
- September 11, 2008
- August 11, 2008
- August 4, 2008
- July 25, 2008
- July 7, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
